接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析 - Suppr

Suppr

超能文献

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.

作者信息

Liao Shu-Yi, Gerber Anthony N, Zelarney Pearlanne, Make Barry, Wechsler Michael E

机构信息

National Jewish Health Denver, Colorado.

出版信息

Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.

DOI:10.1164/rccm.202203-0599LE

PMID:35549647

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9716899/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/094b/9716899/19d0e926f1f3/rccm.202203-0599LEf1.jpg

相似文献

SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析

Am J Respir Crit Care Med. 2022 Sep 1;206(5):644-648. doi: 10.1164/rccm.202203-0599LE.

Reply to Liao : SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis.对廖的回复：接受生物治疗的哮喘患者对SARS-CoV-2 mRNA疫苗的抗体反应：一项真实世界分析。

Am J Respir Crit Care Med. 2022 Sep 1;206(5):647-648. doi: 10.1164/rccm.202205-0979LE.

Impaired SARS-CoV-2 mRNA Vaccine Antibody Response in Chronic Medical Conditions: A Real-World Analysis.慢性疾病中严重急性呼吸综合征冠状病毒2（SARS-CoV-2）mRNA疫苗抗体反应受损：一项真实世界分析

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。

Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.

Effectiveness and Durability of mRNA Vaccine-Induced SARS-CoV-2-Specific Humoral and Cellular Immunity in Severe Asthma Patients on Biological Therapy.mRNA 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫在接受生物治疗的重症哮喘患者中的有效性和持久性。

Front Immunol. 2022 May 20;13:892277. doi: 10.3389/fimmu.2022.892277. eCollection 2022.

Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia.对依赖输血的地中海贫血患者，AB0 血型对 BNT162b2 新型冠状病毒疫苗 mRNA 抗体反应无影响。

Acta Biomed. 2022 May 11;93(2):e2022134. doi: 10.23750/abm.v93i2.12819.

Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?血液透析患者对 SARS-CoV-2 疫苗的抗体反应：灭活疫苗有效吗？

Ther Apher Dial. 2022 Aug;26(4):769-774. doi: 10.1111/1744-9987.13752. Epub 2021 Nov 16.

Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein.ABO血型多态性对针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）刺突蛋白的新冠病毒mRNA疫苗抗体反应的影响不大。

Vox Sang. 2022 Sep;117(9):1126-1127. doi: 10.1111/vox.13341. Epub 2022 Aug 2.

Response to 'Unlikely influence of ABO blood group polymorphism on antibody response to COVID-19 mRNA vaccine against SARS-CoV-2 spike protein'.对《ABO血型多态性对COVID-19 mRNA疫苗针对SARS-CoV-2刺突蛋白抗体反应的影响不太可能》的回应

Vox Sang. 2022 Sep;117(9):1128. doi: 10.1111/vox.13340. Epub 2022 Aug 2.

Antibody response to three SARS-CoV-2 mRNA vaccines in adolescent solid organ transplant recipients.青少年实体器官移植受者对三种SARS-CoV-2 mRNA疫苗的抗体反应。

Am J Transplant. 2022 Oct;22(10):2481-2483. doi: 10.1111/ajt.17085. Epub 2022 May 13.

引用本文的文献

A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology.接受度普利尤单抗治疗的患者使用疫苗的系统评价和专家 Delphi 共识推荐：美国过敏、哮喘和免疫学学会的立场文件。

Ann Allergy Asthma Immunol. 2024 Sep;133(3):286-294. doi: 10.1016/j.anai.2024.05.014. Epub 2024 Jun 5.

Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities.生物疗法在罕见的嗜酸性粒细胞相关疾病中的应用：尚存问题与转化研究机遇。

J Leukoc Biol. 2024 Jul 25;116(2):307-320. doi: 10.1093/jleuko/qiae051.

The BNT162b2 mRNA COVID-19 Vaccine Increases the Contractile Sensitivity to Histamine and Parasympathetic Activation in a Human Ex Vivo Model of Severe Eosinophilic Asthma.BNT162b2 mRNA新冠疫苗在严重嗜酸性粒细胞性哮喘的人体离体模型中增加了对组胺和副交感神经激活的收缩敏感性。

Vaccines (Basel). 2023 Jan 28;11(2):282. doi: 10.3390/vaccines11020282.

本文引用的文献

Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines.度普利尤单抗在减毒活疫苗相关性方面的临床前和临床经验。

J Allergy Clin Immunol Glob. 2021 Dec 8;1(1):9-15. doi: 10.1016/j.jacig.2021.12.003. eCollection 2022 Feb.

Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for Asthma.接受生物疗法治疗哮喘的患者中COVID-19疫苗反应降低。

Am J Respir Crit Care Med. 2022 May 15;205(10):1243-1245. doi: 10.1164/rccm.202111-2496LE.

Chest. 2022 Jun;161(6):1490-1493. doi: 10.1016/j.chest.2021.12.654. Epub 2022 Jan 10.

Towards a population-based threshold of protection for COVID-19 vaccines.针对 COVID-19 疫苗的基于人群的保护阈值。

Vaccine. 2022 Jan 21;40(2):306-315. doi: 10.1016/j.vaccine.2021.12.006. Epub 2021 Dec 15.

The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays.世卫组织 COVID-19 血清学检测国际标准：推动棘突蛋白检测分析方法的标准化。

Int Immunopharmacol. 2021 Nov;100:108095. doi: 10.1016/j.intimp.2021.108095. Epub 2021 Aug 30.

Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial.在患有中度至重度哮喘的青少年和年轻成年患者中，贝那利珠单抗不会损害对季节性流感疫苗的抗体反应：IIIb期ALIZE试验结果

J Asthma Allergy. 2018 Nov 20;11:181-192. doi: 10.2147/JAA.S172338. eCollection 2018.

Dupilumab does not affect correlates of vaccine-induced immunity: A randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis.度普利尤单抗不影响疫苗诱导免疫的相关因素：一项在中重度特应性皮炎成人中进行的随机、安慰剂对照试验。

J Am Acad Dermatol. 2019 Jan;80(1):158-167.e1. doi: 10.1016/j.jaad.2018.07.048. Epub 2018 Aug 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验